Clinical practice guidelines for perioperative management of liver transplantation in patients with severe hepatic failure in China

  • 摘要: 重症肝衰竭是一种以肝功能急剧恶化、多器官功能衰竭和高病死率为特征的临床综合征,内科治疗效果有限,肝移植是挽救患者生命的唯一有效手段。然而患者同时存在的凝血障碍、免疫抑制、感染及心、肾、肺、脑等多器官功能障碍也显著增加了肝移植围手术期的死亡风险,限制了重症肝衰竭患者肝移植救治的开展。基于此,中华医学会器官移植学分会及中国医师协会器官移植医师分会移植免疫专业委员会组织专家通过总结文献、结合临床经验,按照循证医学的原则编写该指南,供肝移植相关专业医师的临床工作参考。

     

    Abstract: Severe liver failure is a clinical syndrome characterized by rapid deterioration of liver function, multi-organ dysfunction and high fatality. Medical treatment has limited efficacy, and liver transplantation is the only effective means to save patients' lives. However, the presence of coagulopathy, immune suppression, infection and dysfunction of multiple organs such as the heart, kidneys, lungs and brain in patients, also significantly increases the risk of death during the perioperative period of liver transplantation, limiting the implementation of liver transplantation for patients with severe liver failure. Based on this, Branch of Organ Transplantation of Chinese Medical Association and Transplant Immunology Committee of Branch of Organ Transplantation Physicians of Chinese Medical Doctor Association have organized experts to summarize the literature and combine clinical experience to write this guideline according to the principles of evidence-based medicine, for reference in the clinical work of physicians related to liver transplantation.

     

/

返回文章
返回